Genetic associations of protein-coding variants in venous thromboembolism

Nat Commun. 2024 Apr 1;15(1):2819. doi: 10.1038/s41467-024-47178-8.

Abstract

Previous genetic studies of venous thromboembolism (VTE) have been largely limited to common variants, leaving the genetic determinants relatively incomplete. We performed an exome-wide association study of VTE among 14,723 cases and 334,315 controls. Fourteen known and four novel genes (SRSF6, PHPT1, CGN, and MAP3K2) were identified through protein-coding variants, with broad replication in the FinnGen cohort. Most genes we discovered exhibited the potential to predict future VTE events in longitudinal analysis. Notably, we provide evidence for the additive contribution of rare coding variants to known genome-wide polygenic risk in shaping VTE risk. The identified genes were enriched in pathways affecting coagulation and platelet activation, along with liver-specific expression. The pleiotropic effects of these genes indicated the potential involvement of coagulation factors, blood cell traits, liver function, and immunometabolic processes in VTE pathogenesis. In conclusion, our study unveils the valuable contribution of protein-coding variants in VTE etiology and sheds new light on its risk stratification.

MeSH terms

  • Blood Coagulation Factors / genetics
  • Exome
  • Genome-Wide Association Study
  • Humans
  • Phosphoproteins / genetics
  • Risk Factors
  • Serine-Arginine Splicing Factors / genetics
  • Venous Thromboembolism* / genetics

Substances

  • Blood Coagulation Factors
  • SRSF6 protein, human
  • Serine-Arginine Splicing Factors
  • Phosphoproteins